Focus Antitrust - 17 March 2021
In The News
CMA obtains director disqualification undertakings in rolled lead cartel case
The CMA has obtained director disqualification undertakings from three directors for their participation in a cartel relating to the rolled lead market. This follows the CMA’s infringement decision in relation to the cartel. Click here.
CMA joins working group of other competition authorities to consider approach on pharma mergers
The CMA has joined a working group of other competition authorities to consider the approach to investigating pharmaceutical mergers. The group comprises the U.S. Federal Trade Commission, the Canadian Competition Bureau, the European Commission, the U.S. Department of Justice, and Offices of State Attorneys General. Click here.
- The CMA has published an update on the work of its coronavirus taskforce. Click here.